🏢 官网IRINDVCodex · 实盘不做把握 9/10
北京时间·🕒 发布 22:00:27时区推断·⟳ 抓取 22:01:21·⚡ 决策 07-23 22:02:49 +1m28s·96.0 天前
Indivior宣布将于8月4日披露二季度业绩并举行电话会
这只是公司例行披露二季度业绩和 webcast 的日程通知，未包含业绩数字、指引变化、产品进展或订单等新增基本面信息。
📄 原文INDV↗ 原文
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it…
不做 Indivior（INDV.US）
例行业绩披露日程通知，无业绩数字、指引变化或可量化新增催化，当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-23 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是公司例行披露二季度业绩和 webcast 的日程通知，未包含业绩数字、指引变化、产品进展或订单等新增基本面信息。
主要风险
- 真正可交易的信息需等2026-08-04业绩正文和管理层指引披露后再重新研判。
原文全文
展开原文 · 2,161 字
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.
Live webcast link: https://edge.media-server.com/mmc/p/yoi9z435
Participants may access the presentation telephonically by registering with the following link:
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities – we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.
For Further Information
Investors:
Jason Thompson
Indivior
Tel: 804-402-7123
E-mail: jason.thompson@indivior.com
Media:
Cassie France-Kelly
Indivior
Tel: 804-594-0836
E-Mail: Indiviormediacontacts@indivior.com
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.
Live webcast link: https://edge.media-server.com/mmc/p/yoi9z435
Participants may access the presentation telephonically by registering with the following link:
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine, developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities – we are powering recovery and renewing hope. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/Indivior.
For Further Information
Investors:
Jason Thompson
Indivior
Tel: 804-402-7123
E-mail: jason.thompson@indivior.com
Media:
Cassie France-Kelly
Indivior
Tel: 804-594-0836
E-Mail: Indiviormediacontacts@indivior.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。